Previous Page  26 / 28 Next Page
Information
Show Menu
Previous Page 26 / 28 Next Page
Page Background

Notes:

Volume 6, Issue 4 (Suppl)

Clin Pharmacol Biopharm, an open access journal

ISSN: 2167-065X

Page 50

Euro Biopharma & Ethnopharmacology 2017

November 09-11, 2017

&

6

th

International Conference and Exhibition on

November 09-11, 2017 Vienna, Austria

4

th

EUROPEAN BIOPHARMA CONGRESS

PHARMACOLOGY AND ETHNOPHARMACOLOGY

Joint Event

Identification of bioactive peptides from enzymatic hydrolysis of royal jelly

Hesham R El-Seedi

1,3

, Adam A Strömstedt

1

,Ulf Göransson

1

and

Aida Abd El-Wahed

1,2

,

1

Uppsala University, Sweden

2

Plant Protection Research Institute - Agricultural Research Centre, Egypt

3

El-Menoufia University, Egypt

R

oyal jelly (RJ) has been widely used in traditional consumables and in skin creams and ointments for health promotion. RJ is rich

in bioactive constituents such as jelleines, 10-hydroxy-2-decenoic acid, royalisin as well as the major royal jelly proteins (MRJPs),

all of which have shown antimicrobial effect

in vitro

. However, the characterization of RJ is far from complete, and the development

of new characterization techniques is allowing the discovery of new compounds. Many new bioactive peptides have been identified

using enzymatic hydrolysis as a tool. Enzymatic hydrolysis of RJ has verified the presence of peptides with anti-oxidant and anti-

hypertensive activity. In the current work, using bioassay guided fractionation of RJ enzymatic digests; a total of 42 peptides were

identified. The peptides, all belonging to the Apis mellifera genome, were identified using a combination of mass spectrometry

and bioinformatics tools. Bioassay guided isolation led to the isolation and structure elucidation of three peptides with promising

antimicrobial activity. These finding support the use of RJ as food preservative and its potential application as antibiotic.

hesham.el-seedi@fkog.uu.se

Hesham El-Seedi et al., Clin Pharmacol Biopharm 2017, 6:4(Suppl)

DOI: 10.4172/2167-065X-C1-025